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Summary
Tuberous sclerosis(TS) is an autosomal dominant disease 
caused by mutations in TSC1 and TSC2 genes. TSC2 
gene is located in chromosome 16p13.3, adjacent to 
PKD1 gene, responsible for the autosomal dominant 
polycystic kidney disease. In a rare subgroup of patients, 
the presence of a deletion which simultaneously affects 
the TSC2 and PKD1 genes has been confirmed. TSC2/
PKD1-Contiguous Gene Syndrome is characterised by 
the early appearance of autosomal dominant polycystic 
kidney disease in combination with several phenotypic 
manifestations of TS. We present a 13-year-old girl with 
bilateral renal cysts detected at the age of 9 months. 
At the age of 13, she was referred to the Dermatology 
Outpatients Clinic due to a facial cutaneous eruption. 
She presented with facial erythema, fibroadenomas 
with malar distribution and disseminated hypomelanotic 
macules, meeting the criteria for TS. TSC2/PKD1 
Contiguous Gene Syndrome deletion was suspected, 
being later confirmed by genetic testing.
Background
Tuberous sclerosis (TS) is a neurocutaneous auto-
somal dominant disease with complete penetrance 
but with a broad intrafamilial and interfamilial 
phenotypic variability. However, it is estimated that 
over 60% of all cases are caused by new mutations.1 
Its incidence is up to 1/6000 to 1/10 000 live births, 
with a population prevalence of around 1/20 000.1–3 
It is caused by mutations in the TSC1 gene, located 
in the long arm of chromosome 9 (9q34), which 
is responsible for the codification of the protein 
hamartin, or in the TSC2 gene, located in the short 
arm of chromosome 16 (16p13), encoding for 
tuberin. Inactivation of the TSC1 or TSC2 gene 
causes uncontrolled cellular cycle progression with 
proliferation of hamartomas in multiple organs and 
systems.2–4 TSC2 mutation is frequently associated 
with a more severe phenotype. However, there are 
reports of milder forms caused by TSC2 mutations.5
TS is a multisystemic disorder, characterised by 
the formation of hamartomas in the central nervous 
system, skin, eye, kidney, lung, heart, liver, muscu-
loskeletal and gastrointestinal system. Neurolog-
ical manifestations are extremely heterogeneous, 
ranging from normal cognitive function without 
seizures to mental retardation and epilepsy refrac-
tory to treatment. The more common dermato-
logical manifestations are hypomelanotic macules 
and facial angiofibromas (75% of patients with 
TS). Shagreen patch is present in the lumbar sacral 
region in 20%–30% of patients and ungual and 
periungual fibromas (Koënen tumours) are present 
in 20% of cases, being more common in adults 
and teenagers.6 7 The most frequent renal mani-
festations are angiomyolipomas and renal cysts. 
Renal cysts may be single or multiple and appear 
in younger ages than angiomyolipomas. According 
to the literature, renal cysts appear earlier and in 
greater number in patients with TSC2 mutation.8 
Other manifestations may be found: subependymal 
giant cell astrocytomas, cardiac rhabdomyomas, 
lymphangioleiomyomatosis and multifocal micro-
nodular pneumocyte hyperplasia.7 9
Polycystic kidney disease (PKD) may have either 
recessive or dominant autosomal transmission. 
Recessive disease appears, in most cases, during the 
first year of life, usually with serious impairment 
of the renal function. Autosomal dominant PKD 
incidence is up to 1/1000 individuals. In 85% of 
cases, it results from PKD1 gene mutation, with the 
remaining 15% being caused by PKD2 gene muta-
tion. It is characterised by bilateral renal cysts and 
progression to end-stage kidney failure.8 9 Other 
possible manifestations are hepatic and pancre-
atic cysts, aortic and cerebral aneurysms, hepatic 
fibrosis, intestinal diverticula and heart valve 
defects.
Although PKD and TS are two different genetic 
diseases, there is a rare subgroup of patients where 
the association between both entities is well estab-
lished—the so called TSC2/PKD1 Contiguous Gene 
Syndrome. This syndrome occurs due to a large 
deletion involving the genes responsible for both 
diseases, the TSC2/PKD1 genes.8 9
caSe preSentation
We present a 13-year-old girl, with unremarkable 
family history and without consanguinity. She was 
delivered at 38 weeks without antenatal or peri-
natal complications, namely prenatal ultrasono-
graphic alterations. At the age of 9 months, she 
was referred to the paediatric nephrology due to 
bilateral polycystic kidneys found on ultrasound, 
performed for evaluation of a left flank palpable 
mass. Screening of family members for kidney 
and hepatic cysts was negative. She has normal 
body growth and psychomotor development. 
Ultrasounds revealed large kidneys with multiple 
cysts (figure 1). Kidney function, blood pressure 
and microalbuminuria remained within normal 
range. At the age of 10, she was referred to the 
paediatric dermatology due to the appearance of 
a cutaneous eruption on the face. She presented 
with facial erythema and angiofibromas with malar 
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distribution (figure 2) and various hypopigmented maculas 
in the upper body, arms and legs, meeting the criteria for TS. 
Afterwards, parents mentioned that some lesions were already 
present in the first years of age. Repeat ultrasound (at 10 years 
old) identified two nodules, suggestive of angiomyolipomas, in 
the left kidney. Diagnostic hypothesis of TSC2/PKD1 Contig-
uous Gene Syndrome was placed, which was confirmed by the 
genetic testing.
inveStigationS
Laboratory investigations, including routine haematolog-
ical and biochemical workup, were normal. At the age of 
13, microalbuminuria (52.00 µg/mL) was detected, with 
normal blood pressure. Brain MRI showed multiple corti-
cosubcortical lesions involving both cerebral hemispheres, 
hypointense on T1-weighted images and hyperintense 
on T2-weighted images, with morphological character-
istics compatible with cortical tubers (figure 3), as well 
as multiple calcified subependymal nodules. Echocardio-
gram was normal, and ophthalmologic evaluation showed 
no hamartomas or other alterations. The genetic testing 
revealed a heterozygous deletion which included the TSC2 
genes (exon 37) and the terminal portion of the PKD1 
gene.
outcome and follow-up
At 13 years of age, patient continued to be seizure free; 
she had normal cognitive functions and an unremarkable 
neurological examination. She had persistent hypopig-
mented maculas in the upper body, arms and legs, without 
Shagreen patch or Koënen tumours. Facial lesions signifi-
cantly improved with topical sirolimus.
During follow-up, her renal function and blood pressure 
remained within normal limits. Cardiac and ophthalmolog-
ical evaluations remained unremarkable. Patient was started 
on enalapril 10 mg once daily for microalbuminuria, with 
subsequent improvement.
figure 1 Renal ultrasonographic: enlarged kidneys with multiple cystic formations.
figure 2 Facial erythema and angiofibromas with malar distribution.
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diScuSSion
Brook-Carter et al first described the TSC2/PKD1 Contiguous 
Gene Syndrome in 1994. It is caused by a deletion that affects 
TSC2 and PKD1 genes, both are located on chromosome 16 
at position 16p13.3, separated by only a few nucleotides. It is 
characterised by the presence of major bilateral kidney cysts, 
usually present at birth or appearing in the first years of life.4 8 10 
Diagnosis is established by genetic testing, using the multiplex 
ligation-dependent probe amplification technique.8 11 12 Years 
later, Sampson et al studied 27 patients with TS and multiple 
bilateral renal cysts and found contiguous deletions of TSC2 and 
PKD1 in 22 patients.1–3 Since then, a few other case reports were 
published. In 2014, Ismail et al described two novel gross dele-
tions of TSC2 gene in two Malaysian patients with TS complex 
and TSC2/PKD1 contiguous gene deletion syndromes, respec-
tively. One deletion involved exons 26–31, and the other dele-
tion involved exons 32–41 which is contiguous into adjacent 
PKD1.13
Kidney cysts may be found in both TS and autosomal domi-
nant PKD, and the contribution of each gene to its appearance is 
unknown. However, it is estimated that 2% to 3% of patients with 
TS have the contiguous deletion of TSC2/PKD1 gene, causing 
a more severe phenotype of polycystic kidney with frequent 
progression to kidney failure within first or second decade of 
life.4 12 14–16 Pathophysiology of renal cysts is unknown, but it is 
believed that the complete inactivation of the PKD1 gene may be 
implicated. In the series published by Sampson et al, 22 patients 
had contiguous deletions of TSC2 and PKD1. In 17 patients with 
constitutional deletions, cystic disease was severe, with early 
renal insufficiency. Fourteen patients were diagnosed with renal 
cysts in the first year of life, and three evolved to terminal kidney 
failure by the age of 20.2 3
Although clinical or imaging findings of TSC may not mani-
fest early in life, radiological findings can be the first to suggest 
a diagnosis of TSC2/ADPKD1 contiguous gene syndrome and 
prompt investigation in search of TSC lesions, namely imaging 
and directed skin examination. Renal imaging findings in TSC2/
ADPKD1 contiguous gene syndrome progress over time and 
demonstrate a specific pattern of renal disease different from 
typical TS complex. During infancy and early childhood, there 
are multiple renal cysts, with progressive enlargement of the 
kidneys and of the renal cysts. Recognition of this pattern by 
the radiologist may prompt further screening for TSC pheno-
type and help in early diagnosis. Histopathological features of 
skin lesions in TSC2/PKD1 contiguous deletion syndrome are 
similar to those encountered in TS. Hence, clinical awareness 
and appropriate molecular investigation of TSC2/PKD1 contig-
uous gene syndrome are essential in all patients with a typical 
phenotype of TSC in early years of life because of the severity 
of the renal alterations in these patients.17 One should consider 
the TSC2/PKD1 Contiguous Gene Syndrome in patients with TS 
who present with congenital or early age appearing bilateral renal 
cysts, without family history of autosomal dominant or auto-
somal recessive PKD. TSC2/PKD1 Contiguous Gene Syndrome 
should also be considered in children less than 2 years of age 
with renal cysts and no family history of autosomal dominant or 
autosomal recessive PKD. The additional finding of renal angi-
omyolipomas in this setting is virtually pathognomonic of TSC. 
Patients who will require renal transplantation in the future may 
benefit from mTOR inhibitors, which are immunosuppressive 
agents that reduce the size of benign tumours in TS as well as 
the risk of rupture and bleeding.18 Most cases described in the 
literature refer to patients diagnosed with TS in which, during 
the follow-up of their disease, bilateral kidney cysts are detected. 
In our patient, the chronological order was different: there was 
a follow-up for PKD without family history or genetic study, and 
the latter detection of cutaneous lesions led to suspicion of TS.
Although patients with TS complex exhibit a high rate of 
epilepsy and cognitive problems, our patient had a normal 
cognitive development with no seizures. In the study published 
by Kassiri et al, a cohort of 24 patients with TS complex under-
went brain MRI, electroencephalogram and neuropsychological 
evaluation. The study reported a negative correlation between 
number of cortical tubers an IQ score.19
Microalbuminuria was the only abnormality in renal func-
tion that the patient had at the time of diagnosis. Since she has 
the described mutation, and the combination of mutations of 
TSC2 and PKD1 genes is associated with severe kidney lesion, it 
is expected that in the future she will evolve to chronic kidney 
failure.
Authors also consider that this case illustrates the relevance of 
a detailed physical examination, significance of the cutaneous 
figure 3 Tuber cortical.
learning points
 ► The TSC2/PKD1 contiguous gene syndrome is characterised by 
the early appearance of manifestations of polycystic kidney 
disease in combination with varied phenotypic expressions of 
Tuberous sclerosis (TS).
 ► This diagnosis should be considered in patients with 
manifestations of kidney polyscystosis and stigmas of TS.
 ► Because prognosis of renal and neurological functions is 
worse in this subgroup of patients, earlier detection and 
treatment may help preventing kidney and neurological 
deterioration.
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manifestations (which are sometimes unnoticed or unvalued) 
in children with polycystic renal disease, as well as pertinence 
of the multidisciplinary collaboration between paediatrics and 
dermatology in the diagnosis of TSC2/PKD1 contiguous gene 
syndrome.
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